These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 7511100)
1. Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. Savino R; Lahm A; Salvati AL; Ciapponi L; Sporeno E; Altamura S; Paonessa G; Toniatti C; Ciliberto G EMBO J; 1994 Mar; 13(6):1357-67. PubMed ID: 7511100 [TBL] [Abstract][Full Text] [Related]
2. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. Horsten U; Müller-Newen G; Gerhartz C; Wollmer A; Wijdenes J; Heinrich PC; Grötzinger J J Biol Chem; 1997 Sep; 272(38):23748-57. PubMed ID: 9295319 [TBL] [Abstract][Full Text] [Related]
3. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. Paonessa G; Graziani R; De Serio A; Savino R; Ciapponi L; Lahm A; Salvati AL; Toniatti C; Ciliberto G EMBO J; 1995 May; 14(9):1942-51. PubMed ID: 7744001 [TBL] [Abstract][Full Text] [Related]
4. Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiation. Ehlers M; Grötzinger J; Fischer M; Bos HK; Brakenhoff JP; Rose-John S J Interferon Cytokine Res; 1996 Aug; 16(8):569-76. PubMed ID: 8877726 [TBL] [Abstract][Full Text] [Related]
5. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404 [TBL] [Abstract][Full Text] [Related]
6. Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6. Li H; Nicholas J J Virol; 2002 Jun; 76(11):5627-36. PubMed ID: 11991991 [TBL] [Abstract][Full Text] [Related]
7. The molecular design of human IL-6 receptor antagonists. Lahm A; Savino R; Salvati AL; Cabibbo A; Ciapponi L; Demartis A; Toniatti C; Paonessa G; Altamura S; Ciliberto G Ann N Y Acad Sci; 1995 Jul; 762():136-50; discussion 150-1. PubMed ID: 7668525 [No Abstract] [Full Text] [Related]
8. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface. Salvati AL; Lahm A; Paonessa G; Ciliberto G; Toniatti C J Biol Chem; 1995 May; 270(20):12242-9. PubMed ID: 7744875 [TBL] [Abstract][Full Text] [Related]
9. Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells. Ehlers M; de Hon FD; Bos HK; Horsten U; Kurapkat G; van De Leur HS; Grötzinger J; Wollmer A; Brakenhoff JP; Rose-John S J Biol Chem; 1995 Apr; 270(14):8158-63. PubMed ID: 7713920 [TBL] [Abstract][Full Text] [Related]
10. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity. Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370 [TBL] [Abstract][Full Text] [Related]
12. Leucine-58 in the putative 5th helical region of human interleukin (IL)-6 is important for activation of the IL-6 signal transducer, gp130. de Hon FD; Klaasse Bos HK; Ebeling SB; Grötzinger J; Kurapkat G; Rose-John S; Aarden LA; Brakenhoff JP FEBS Lett; 1995 Aug; 369(2-3):187-91. PubMed ID: 7649255 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction. Kalai M; Montero-Julian FA; Grötzinger J; Fontaine V; Vandenbussche P; Deschuyteneer R; Wollmer A; Brailly H; Content J Blood; 1997 Feb; 89(4):1319-33. PubMed ID: 9028955 [TBL] [Abstract][Full Text] [Related]
14. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors. Sporeno E; Paonessa G; Salvati AL; Graziani R; Delmastro P; Ciliberto G; Toniatti C J Biol Chem; 1994 Apr; 269(15):10991-5. PubMed ID: 8157624 [TBL] [Abstract][Full Text] [Related]
15. Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation. Pflanz S; Kurth I; Grötzinger J; Heinrich PC; Müller-Newen G J Immunol; 2000 Dec; 165(12):7042-9. PubMed ID: 11120832 [TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. Yawata H; Yasukawa K; Natsuka S; Murakami M; Yamasaki K; Hibi M; Taga T; Kishimoto T EMBO J; 1993 Apr; 12(4):1705-12. PubMed ID: 8467812 [TBL] [Abstract][Full Text] [Related]
17. Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis. Tacken I; Dahmen H; Boisteau O; Minvielle S; Jacques Y; Grötzinger J; Küster A; Horsten U; Blanc C; Montero-Julian FA; Heinrich PC; Müller-Newen G Eur J Biochem; 1999 Oct; 265(2):645-55. PubMed ID: 10504396 [TBL] [Abstract][Full Text] [Related]
18. A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor. Dittrich E; Haft CR; Muys L; Heinrich PC; Graeve L J Biol Chem; 1996 Mar; 271(10):5487-94. PubMed ID: 8621406 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6. Boulanger MJ; Chow DC; Brevnova E; Martick M; Sandford G; Nicholas J; Garcia KC J Mol Biol; 2004 Jan; 335(2):641-54. PubMed ID: 14672670 [TBL] [Abstract][Full Text] [Related]
20. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. Aoki Y; Narazaki M; Kishimoto T; Tosato G Blood; 2001 Nov; 98(10):3042-9. PubMed ID: 11698289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]